Among patients with EOT-AFP <5.3 ng/mL, a significantly higher percentage of patients had normal limits of AFP and DCP in comparison to those with EOT-AFP ≥5.3 ng/mL at the onset of HCC (p = 0.020). This evidence concerns the gene ACE and hepatocellular carcinoma.